and regulatory authorities to consider when assessing potential clinical applications of human germline genome editing. Powerful new gene-editing technologies, such as CRISPR-Cas9, hold great promise ...
After the reported birth of CRISPRed babies in China, experts want to take time to consider the scientific, social, ethical, and philosophical consequences of editing heritable human DNA ... Editing ...
Advancements in germline genome editing have accelerated ... DOI: 10.1038/d41586-024-04105-7 We need to talk about human genome editing, Nature (2025). DOI: 10.1038/d41586-025-00015-4 ...
The use of genome editing in human embryos for reproductive purposes is highly controversial and is currently prohibited in many countries. There are concerns about the safety, efficacy, and long-term ...
In the wake of reports of CRISPRed babies born in China, a bipartisan resolution “opposes the experiments that resulted in pregnancies using genome-edited human ... and philosophical consequences of ...
The first two days of the summit focused largely on somatic human genome editing, where the cells being altered are non-reproductive cells - as a result genetic changes cannot be passed on to future ...
CRISPR-Cas9 genome ... in the human genome. Retinitis pigmentosa (RP) is the most common type of inherited retinal dystrophy without effective treatments. Here, authors apply prime editing ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...
Both germline and somatic alterations are ... Professor Katsushi Tokunaga has been engaged in genome-wide research of human genetic factors for a variety of multi-factorial diseases.
“We are finding the 3D structure of the genome,” said Satoshi Namekawa ... sets up the gene expression program in the male germline.” “This is really showing us how the genomic ...
On top of all that, China forbids gene editing in human reproduction ... are working on in utero genome editing. Done late enough in development it would not alter germline cells, but would ...